Mechanisms of macular edema

CD Haydinger, LB Ferreira, KA Williams… - Frontiers in …, 2023 - frontiersin.org
Macular edema is the pathological accumulation of fluid in the central retina. It is a
complication of many retinal diseases, including diabetic retinopathy, retinal vascular …

Optical coherence tomography in the management of diabetic macular oedema

SKH Szeto, TYY Lai, S Vujosevic, JK Sun… - Progress in Retinal and …, 2023 - Elsevier
Diabetic macular oedema (DMO) is the major cause of visual impairment in people with
diabetes. Optical coherence tomography (OCT) is now the most widely used modality to …

Deep learning prediction of response to anti-VEGF among diabetic macular edema patients: Treatment response analyzer system (TRAS)

SA Alryalat, M Al-Antary, Y Arafa, B Azad, C Boldyreff… - Diagnostics, 2022 - mdpi.com
Diabetic macular edema (DME) is the most common cause of visual impairment among
patients with diabetes mellitus. Anti-vascular endothelial growth factors (Anti-VEGFs) are …

Rho-kinase inhibitors for the treatment of refractory diabetic macular oedema

M Mateos-Olivares, L García-Onrubia… - Cells, 2021 - mdpi.com
Diabetic macular oedema (DMO) is one of the leading causes of vision loss associated with
diabetic retinopathy (DR). New insights in managing this condition have changed the …

[HTML][HTML] Patient-centered economic burden of exudative age-related macular degeneration: retrospective cohort study

K Choi, SJ Park, S Han, Y Mun, DY Lee… - JMIR Public Health …, 2023 - publichealth.jmir.org
Background Exudative age-related macular degeneration (AMD), one of the leading causes
of blindness, requires expensive drugs such as anti–vascular endothelial growth factor …

Treat and extend regimen for diabetic macular oedema—A systematic review and meta-analysis

SY Lim, WM Wong, I Seah, HW Chan, X Su… - Graefe's Archive for …, 2023 - Springer
Purpose Various treatment regimens are currently practiced in the treatment of CI-DMO
(centre-involving diabetic macular oedema). In recent years, there has been a growing body …

Subthreshold micropulse laser versus standard laser for the treatment of central-involving diabetic macular oedema with central retinal thickness of< 400µ: a cost …

H Mistry, M Maredza, C Campbell, N Lois - BMJ open, 2023 - bmjopen.bmj.com
Objectives To estimate the economic costs, health-related quality-of-life outcomes and cost-
effectiveness of subthreshold micropulse laser (SML) versus standard laser (SL) for the …

Lichen myxedematosus associated with monoclonal gammopathy of undetermined significance: A case report and literature review

H Huang, SX Qian - Frontiers in Medicine, 2023 - frontiersin.org
Lichen myxedematosus (LM) is an idiopathic cutaneous mucinosis disorder, and
monoclonal gammopathy of undetermined significance (MGUS) is a preneoplastic plasma …

[PDF][PDF] 新生血管性年龄相关性黄斑变性对抗VEGF 治疗的耐药性危险因素分析

范梅吟, 但超, 王峥嵘, 徐洋… - Progress in Modern …, 2022 - biomed.cnjournals.com
摘要目的: 探究新生血管性年龄相关性黄斑变性对抗血管内皮生长因子(VEGF)
治疗的耐药性危险因素. 方法: 选取2019 年5 月至2021 年5 月于我院接受治疗的90 例nAMD …

Nocturnal normobaric hyperoxia treatment in a case of chronic diabetic macular edema

S Song, CA Lemire, B Seto… - European Journal of …, 2023 - journals.sagepub.com
Purpose To study the long-term anatomic and physiologic effects of nocturnal normobaric
hyperoxia (NNBH) in a patient with treatment-resistant diabetic macular edema (DME) …